New Roche data at the 2019 AAN Annual Meeting showcase breadth and promise of neuroscience portfolio

Roche today announced new data for its approved and investigational medicines for the treatment of neurological conditions will be presented at the 71st American Academy of Neurology (AAN) Annual Meeting from 4-10 May in Philadelphia, PA. Presentations include data from a pivotal study for risdiplam in spinal muscular atrophy (SMA), which has the potential to become the first oral treatment for this community.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news